Back

Impact of poor below-the-knee run-off on stent failure of femoro-popliteal arteries in healthy swine model.

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Peripheral artery disease: tackling the burden and improving outcomes Pathophysiology and Mechanisms ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Norihito Nakamura

Tokai University Hospital, Isehara (Japan)

5 More presentations in this session

Presentation thumbnail
Nationwide trends and projections of peripheral arterial disease among Danish adults
Mrs M. Soegaard (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Evaluation of Takayasu's arteritis activity by ultrasound localization microscopy
Doctor G. Goudot (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Elevated Lipoprotein(a) levels increase Major Adverse Limb Event
Doctor A. Guedon (Paris, FR)
Abstract Slides Video
Presentation thumbnail
Optimal strategy for antiplatelet therapy after endovascular revascularization in patients with lower extremity artery disease
Doctor J. Seo (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Evaluation of the benefit of rivaroxaban on VOYAGER PAD primary composite of limb, heart and brain outcomes using the global rank and win ratio methods
Doctor M. Bonaca (Aurora, US)
Abstract Slides Video

Access the full session

Session thumbnail
Peripheral artery disease: tackling the burden and improving outcomes
Video

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022
You may be interested in
thumbnail
Congress Presentation
Antiplatelet therapy and prognosis at the onset of stent thrombosis
thumbnail
Congress Presentation
In vivo assessment of neointimal proliferation after drug-eluting stent implantation; comparison between findings using by coronary angioscopy and optical coherence tomography.
thumbnail
Congress Presentation
Clinical impact and lesion characteristics of suboptimal optical coherence tomography stent deployment in patients with acute myocardial infarction

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources